Checkpoint control of cytokinesis

胞质分裂的检查点控制

基本信息

  • 批准号:
    9111001
  • 负责人:
  • 金额:
    $ 37.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-05 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cytokinesis, the physical division of one cell into two daughter cells, is the final stage of the cell reproductive cycle and the least well understood. Correctly timing the process of cytokinesis so that it occurs only after chromosome replication and segregation is necessary to prevent catastrophic genomic instability and accordingly, cytokinesis is strictly regulated in concert with other events of the cell cycle. We have made significant progress in identifying and characterizing proteins essential for cytokinesis using a leading model organism for cytokinesis studies, the fission yeast Schizosaccharomyces pombe. We now propose to gain a better understanding of how these myriad proteins are controlled. A Hippo-related protein kinase cascade termed the septation initiation network (SIN) controls assembly, maintenance, and constriction of the actomyosin contractile ring and is therefore the immediate upstream regulator of cytokinesis in S. pombe. Our knowledge is limited however as to what ultimately ensures the coordination of SIN activity and thus cytokinesis, with other events of mitosis. Among other mechanisms, SIN function is directly inhibited by the ubiquitin ligase Dma1 and this comprises a second branch of mitotic checkpoint signaling. Given our new understanding that Dma1 is a general inhibitor of the polo-like kinase, Plo1 at mitotic initiation, we will study whether this mechanism of controlling mitotic inhibition is shared with the human tumor suppressor CHFR. We will determine how Dma1 activity and localization are controlled throughout the cell cycle by upstream pathways including one comprising CK1. We propose a comprehensive set of biochemical and cell biological experiments to fill these knowledge gaps. These focused mechanistic studies will be complemented with phosphoproteomic and genetic screens designed to better understand the signaling landscape during mitosis. Although some wiring aspects of the signaling networks may be found to vary between organisms, these studies will have a major impact for understanding how cytokinesis can in principle be entrained with other events of mitosis to protect genome integrity.
描述(申请人提供):细胞质分裂,一个细胞分裂成两个子细胞,是细胞繁殖周期的最后阶段,也是最不为人所知的。正确计时胞质分裂过程,使其仅在染色体复制和分离之后发生,对于防止灾难性的基因组不稳定是必要的,因此,胞质分裂与细胞周期的其他事件相一致地受到严格调控。我们使用胞质分裂研究的领先模式生物--裂殖酵母庞贝,在鉴定和鉴定胞质分裂所必需的蛋白质方面取得了重大进展。我们现在建议更好地了解这些无数的蛋白质是如何被控制的。河马相关的蛋白激酶级联被称为分隔起始网络(SIN),控制着肌动球蛋白收缩环的组装、维持和收缩,因此是S.pombe胞质分裂的直接上游调节因子。然而,我们对最终确保SIN活性以及胞质分裂与其他有丝分裂事件的协调的了解有限。在其他机制中,SIN功能直接被泛素连接酶Dma1抑制,这是有丝分裂检查点信号的第二个分支。鉴于我们对Dma1是Polo样激酶的一般抑制物的新理解,Plo1在有丝分裂开始时, 我们将研究这种控制有丝分裂抑制的机制是否与人类肿瘤抑制基因CHFR相同。我们将确定Dma1的活性和定位如何通过上游途径控制整个细胞周期,其中包括一条包含CK1的途径。我们提出了一套全面的生化和细胞生物学实验来填补这些知识空白。这些重点的机制研究将得到磷酸蛋白质组和基因筛选的补充,旨在更好地了解有丝分裂期间的信号格局。尽管信号网络的一些连接方面可能被发现在不同的生物体之间有所不同,但这些研究将对理解细胞质分裂如何原则上与其他有丝分裂事件一起保护基因组完整性具有重大影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathleen L Gould其他文献

Kathleen L Gould的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathleen L Gould', 18)}}的其他基金

Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    10152616
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    10800229
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    9921422
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    10613993
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    10794021
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    10392903
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    9928170
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Regulation of cytokinesis
胞质分裂的调节
  • 批准号:
    10380944
  • 财政年份:
    2019
  • 资助金额:
    $ 37.62万
  • 项目类别:
Checkpoint control of cytokinesis
胞质分裂的检查点控制
  • 批准号:
    8799120
  • 财政年份:
    2014
  • 资助金额:
    $ 37.62万
  • 项目类别:
FASEB SRC on Yeast Chromosome Structure, Replication and Segregation
FASEB SRC 关于酵母染色体结构、复制和分离
  • 批准号:
    8781775
  • 财政年份:
    2014
  • 资助金额:
    $ 37.62万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了